Skip to main content

Investigación y educación

Submitted by remote_content on

Diaz A. Quantitative sensory testing: a good tool to identify subclinical neuropathy in ATTRV30M amyloidosis patients? Amyloid.

Investigación y Educación

"Background Quantitative sensory testing (QST) has been one of the neurophysiological tools used for follow-up and disease progression assessment in ATTRv amyloidosis. We aimed to detect the utility of QST in identifying subclinical neuropathic involvement in ATTRV30M amyloidosis carriers.

Conclusions QST, in particular CDT, HP 5 and HP 0.5 modalities, seems a good tool to identify subclinical neuropathy in ATTRv amyloidosis carriers, with CDT showing a higher sensitivity to detect and early neuropathic involvement."

Read full article

Artículos que te pueden interesar

Neurología

Structural Protein Effects Underpinning Cognitive Developmental Delay of the PURA p.Phe233del Mutation Modelled by Artificial Intelligence and the Hybrid Quantum Mechanics-Molecular Mechanics Framework. Brain Sci. 2022 Jun

June 30, 2022

Leer más

Neurología

"Multiple sclerosis care units in Latin America: Consensus recommendations about its objectives and functioning implementation. J Neurol Sci."

October 15, 2021

Leer más

Neurología

"on behalf research priorities LACTRIMS Working Group. Research priorities in multiple sclerosis in Latin America: A multi- stakeholder call to action to improve patients care: Research priorities in MS in LATAM. Mult Scler Relat Disord."

May 24, 2021

Leer más